| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | Rab GDP-dissociation inhibitor activity | 7.90e-05 | 2 | 178 | 2 | GO:0005093 | |
| GeneOntologyBiologicalProcess | cilium movement | DNAH3 OFD1 CATSPERD ADAM7 ASH1L CFAP43 CFAP54 CCNYL1 TMEM232 ZMYND10 CFAP206 DYNC1H1 | 2.78e-06 | 261 | 177 | 12 | GO:0003341 |
| GeneOntologyBiologicalProcess | sperm motility | CATSPERD ADAM7 ASH1L CFAP43 CFAP54 CCNYL1 TMEM232 ZMYND10 CFAP206 | 4.52e-05 | 193 | 177 | 9 | GO:0097722 |
| GeneOntologyBiologicalProcess | multi-pass transmembrane protein insertion into ER membrane | 5.02e-05 | 9 | 177 | 3 | GO:0160063 | |
| GeneOntologyBiologicalProcess | host-mediated regulation of intestinal microbiota composition | 7.13e-05 | 10 | 177 | 3 | GO:0048874 | |
| GeneOntologyBiologicalProcess | positive regulation of motile cilium assembly | 7.32e-05 | 2 | 177 | 2 | GO:1905505 | |
| GeneOntologyBiologicalProcess | regulation of motile cilium assembly | 7.32e-05 | 2 | 177 | 2 | GO:1905503 | |
| GeneOntologyBiologicalProcess | maintenance of protein complex location | 7.32e-05 | 2 | 177 | 2 | GO:0098544 | |
| GeneOntologyBiologicalProcess | spermatogenesis | NR2C2 CATSPERD ADAM7 CFTR TSPY4 TSPY9 CFAP43 CCNY SEPTIN2 AXDND1 CFAP54 CCNYL1 TMEM232 BRCA2 CCNA1 CFAP206 CCDC136 HTT | 7.59e-05 | 744 | 177 | 18 | GO:0007283 |
| GeneOntologyBiologicalProcess | cilium movement involved in cell motility | DNAH3 CATSPERD ADAM7 ASH1L CFAP43 CFAP54 CCNYL1 TMEM232 CFAP206 | 8.66e-05 | 210 | 177 | 9 | GO:0060294 |
| GeneOntologyBiologicalProcess | microtubule-based movement | KIF13B DNAH3 OFD1 CATSPERD ADAM7 ASH1L CFAP43 CFAP54 CCNYL1 TMEM232 ZMYND10 CFAP206 DYNC1H1 HTT | 9.50e-05 | 493 | 177 | 14 | GO:0007018 |
| GeneOntologyBiologicalProcess | male gamete generation | NR2C2 CATSPERD ADAM7 CFTR TSPY4 TSPY9 CFAP43 CCNY SEPTIN2 AXDND1 CFAP54 CCNYL1 TMEM232 BRCA2 CCNA1 CFAP206 CCDC136 HTT | 1.03e-04 | 762 | 177 | 18 | GO:0048232 |
| GeneOntologyBiologicalProcess | cilium-dependent cell motility | DNAH3 CATSPERD ADAM7 ASH1L CFAP43 CFAP54 CCNYL1 TMEM232 CFAP206 | 1.04e-04 | 215 | 177 | 9 | GO:0060285 |
| GeneOntologyBiologicalProcess | cilium or flagellum-dependent cell motility | DNAH3 CATSPERD ADAM7 ASH1L CFAP43 CFAP54 CCNYL1 TMEM232 CFAP206 | 1.04e-04 | 215 | 177 | 9 | GO:0001539 |
| GeneOntologyBiologicalProcess | protein insertion into ER membrane | 1.38e-04 | 31 | 177 | 4 | GO:0045048 | |
| GeneOntologyBiologicalProcess | sexual reproduction | NR2C2 CATSPERD ADAM7 CFTR ASH1L TSPY4 SMC4 TSPY9 CFAP43 TUBGCP2 CCNY SEPTIN2 LIF AXDND1 PPP2CA CFAP54 CCNYL1 TMEM232 BRCA2 CCNA1 CFAP206 ANAPC5 CCDC136 HTT CPEB1 | 1.46e-04 | 1312 | 177 | 25 | GO:0019953 |
| GeneOntologyBiologicalProcess | flagellated sperm motility | 2.09e-04 | 186 | 177 | 8 | GO:0030317 | |
| GeneOntologyBiologicalProcess | small GTPase-mediated signal transduction | RALGAPA1 DOCK11 PLEKHG7 RGS19 CHN1 CHN2 GDI1 GDI2 PLEKHG1 PPP2CB PLEKHG3 RIPOR1 ARHGEF4 PSD4 | 2.35e-04 | 538 | 177 | 14 | GO:0007264 |
| GeneOntologyCellularComponent | peptidase complex | 2.03e-05 | 133 | 180 | 8 | GO:1905368 | |
| GeneOntologyCellularComponent | endopeptidase complex | 2.90e-05 | 102 | 180 | 7 | GO:1905369 | |
| GeneOntologyCellularComponent | multi-pass translocon complex | 5.08e-05 | 9 | 180 | 3 | GO:0160064 | |
| GeneOntologyCellularComponent | ER membrane insertion complex | 2.13e-04 | 14 | 180 | 3 | GO:0072379 | |
| GeneOntologyCellularComponent | proteasome complex | 2.81e-04 | 67 | 180 | 5 | GO:0000502 | |
| GeneOntologyCellularComponent | FAR/SIN/STRIPAK complex | 3.91e-04 | 17 | 180 | 3 | GO:0090443 | |
| GeneOntologyCellularComponent | transferase complex | UBR1 ERCC2 ATG13 RGPD1 EXT2 KLHL41 TEX10 TRRAP CCNY MAP3K5 KLHL3 PHKG1 FBXL7 BRCA2 CCNA1 ANAPC5 TMEM258 FBXO15 NAA16 | 6.66e-04 | 963 | 180 | 19 | GO:1990234 |
| GeneOntologyCellularComponent | endoplasmic reticulum protein-containing complex | 7.54e-04 | 125 | 180 | 6 | GO:0140534 | |
| MousePheno | abnormal sperm radial spoke morphology | 1.97e-05 | 6 | 141 | 3 | MP:0031438 | |
| Domain | DUF2012 | 3.38e-06 | 4 | 178 | 3 | PF09430 | |
| Domain | DUF2012 | 3.38e-06 | 4 | 178 | 3 | IPR019008 | |
| Domain | CarboxyPept_regulatory_dom | 5.33e-06 | 13 | 178 | 4 | IPR014766 | |
| Domain | - | 5.33e-06 | 13 | 178 | 4 | 2.60.40.1120 | |
| Domain | CarboxyPept-like_regulatory | 1.72e-05 | 17 | 178 | 4 | IPR008969 | |
| Domain | Carb-bd-like_fold | 4.60e-05 | 8 | 178 | 3 | IPR013784 | |
| Domain | RabGDI | 9.03e-05 | 2 | 178 | 2 | IPR000806 | |
| Domain | Cyclin_Y | 9.03e-05 | 2 | 178 | 2 | IPR012399 | |
| Domain | CHN1/CHN2 | 9.03e-05 | 2 | 178 | 2 | IPR017356 | |
| Domain | CA | 1.17e-04 | 115 | 178 | 7 | SM00112 | |
| Domain | Cadherin | 1.38e-04 | 118 | 178 | 7 | IPR002126 | |
| Domain | Cadherin_tail | 4.12e-04 | 37 | 178 | 4 | PF15974 | |
| Domain | Cadherin_CBD | 4.12e-04 | 37 | 178 | 4 | IPR031904 | |
| Domain | ARM-type_fold | RALGAPA1 DOCK11 NBEAL1 UBR4 PSMD5 TEX10 TRRAP EFR3A RIPOR1 ARMH3 HTT | 4.21e-04 | 339 | 178 | 11 | IPR016024 |
| Domain | CYCLIN | 4.57e-04 | 38 | 178 | 4 | SM00385 | |
| Domain | GDI | 5.35e-04 | 4 | 178 | 2 | PF00996 | |
| Domain | GDP_dissociation_inhibitor | 5.35e-04 | 4 | 178 | 2 | IPR018203 | |
| Domain | - | 5.58e-04 | 40 | 178 | 4 | 1.10.472.10 | |
| Domain | Cadherin_CS | 6.20e-04 | 109 | 178 | 6 | IPR020894 | |
| Domain | Cadherin_C | 6.73e-04 | 42 | 178 | 4 | IPR032455 | |
| Domain | Cadherin_C_2 | 6.73e-04 | 42 | 178 | 4 | PF16492 | |
| Domain | Cyclin-like | 7.36e-04 | 43 | 178 | 4 | IPR013763 | |
| Domain | CADHERIN_1 | 7.49e-04 | 113 | 178 | 6 | PS00232 | |
| Domain | Cadherin | 7.49e-04 | 113 | 178 | 6 | PF00028 | |
| Domain | CADHERIN_2 | 7.85e-04 | 114 | 178 | 6 | PS50268 | |
| Domain | - | 7.85e-04 | 114 | 178 | 6 | 2.60.40.60 | |
| Domain | PH_dom-like | DOCK11 NBEAL1 PLEKHG7 RGPD1 NIBAN2 PLEKHG1 CCM2 PLEKHG3 ARHGEF4 CADPS2 FRMD3 PSD4 | 8.16e-04 | 426 | 178 | 12 | IPR011993 |
| Domain | Cadherin-like | 8.60e-04 | 116 | 178 | 6 | IPR015919 | |
| Domain | PKD_2 | 8.86e-04 | 5 | 178 | 2 | IPR003915 | |
| Pathway | REACTOME_MITOTIC_G2_G2_M_PHASES | OFD1 PSMC4 PSMD5 TUBGCP2 PPP2CA PPP2CB FBXL7 CCNA1 PSME3 DYNC1H1 | 4.38e-06 | 184 | 122 | 10 | MM15145 |
| Pathway | REACTOME_SEPARATION_OF_SISTER_CHROMATIDS | KNTC1 CENPL RGPD1 PSMC4 PSMD5 PPP2CA PPP2CB PSME3 ANAPC5 DYNC1H1 | 6.69e-06 | 193 | 122 | 10 | MM14890 |
| Pathway | REACTOME_MITOTIC_G2_G2_M_PHASES | OFD1 PSMC4 PSMD5 TUBGCP2 PPP2CA PPP2CB FBXL7 CCNA1 PSME3 DYNC1H1 | 9.16e-06 | 200 | 122 | 10 | M864 |
| Pathway | REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION | UBR1 UBR4 PSMC4 RNF213 PSMD5 KLHL41 KLHL3 FBXL7 PSME3 UBE3C ANAPC5 FBXO15 | 1.08e-05 | 299 | 122 | 12 | MM15711 |
| Pathway | REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION | UBR1 UBR4 PSMC4 RNF213 PSMD5 KLHL41 KLHL3 FBXL7 PSME3 UBE3C ANAPC5 FBXO15 | 1.45e-05 | 308 | 122 | 12 | M1070 |
| Pathway | REACTOME_CELL_CYCLE_CHECKPOINTS | KNTC1 CENPL RGPD1 PSMC4 PSMD5 PPP2CA PPP2CB CCNA1 PSME3 ANAPC5 DYNC1H1 | 2.30e-05 | 271 | 122 | 11 | MM15388 |
| Pathway | REACTOME_M_PHASE | KNTC1 OFD1 CENPL RGPD1 SMC4 PSMC4 PSMD5 TUBGCP2 PPP2CA PPP2CB PSME3 ANAPC5 DYNC1H1 | 3.02e-05 | 387 | 122 | 13 | MM15364 |
| Pathway | REACTOME_MITOTIC_METAPHASE_AND_ANAPHASE | KNTC1 CENPL RGPD1 PSMC4 PSMD5 PPP2CA PPP2CB PSME3 ANAPC5 DYNC1H1 | 3.56e-05 | 234 | 122 | 10 | MM14898 |
| Pathway | REACTOME_SEPARATION_OF_SISTER_CHROMATIDS | 4.16e-05 | 191 | 122 | 9 | M29614 | |
| Pathway | REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION | UBR1 UBR4 PSMC4 RNF213 PSMD5 KLHL41 KLHL3 FBXL7 PSME3 UBE3C ANAPC5 FBXO15 | 4.19e-05 | 343 | 122 | 12 | MM15712 |
| Pathway | REACTOME_CELL_CYCLE | KNTC1 OFD1 CENPL RBL1 RGPD1 SMC4 PSMC4 PSMD5 TUBGCP2 PPP2CA PPP2CB FBXL7 CCNA1 PSME3 ANAPC5 DYNC1H1 | 6.27e-05 | 603 | 122 | 16 | MM14635 |
| Pathway | REACTOME_MITOTIC_PROMETAPHASE | 6.43e-05 | 202 | 122 | 9 | MM15362 | |
| Pathway | REACTOME_MITOTIC_SPINDLE_CHECKPOINT | 6.91e-05 | 117 | 122 | 7 | MM15387 | |
| Pathway | REACTOME_CELL_CYCLE_MITOTIC | KNTC1 OFD1 CENPL RBL1 SMC4 PSMC4 PSMD5 TUBGCP2 PPP2CA PPP2CB FBXL7 CCNA1 PSME3 ANAPC5 DYNC1H1 | 9.94e-05 | 561 | 122 | 15 | M5336 |
| Pathway | REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION | UBR1 UBR4 PSMC4 RNF213 PSMD5 KLHL41 KLHL3 FBXL7 PSME3 UBE3C ANAPC5 FBXO15 | 1.14e-04 | 381 | 122 | 12 | M1066 |
| Pathway | REACTOME_MITOTIC_G1_PHASE_AND_G1_S_TRANSITION | 1.34e-04 | 130 | 122 | 7 | MM15146 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | RALGAPA1 KNTC1 SEMA4F CENPL DOCK11 CFTR RGPD1 CPD CHN1 CHN2 ARPC3 PLEKHG1 PPP2CA PPP2CB PLEKHG3 DYNC1H1 | 1.48e-04 | 649 | 122 | 16 | MM15690 |
| Pathway | REACTOME_MITOTIC_METAPHASE_AND_ANAPHASE | 2.10e-04 | 236 | 122 | 9 | M27185 | |
| Pathway | REACTOME_CELL_CYCLE_CHECKPOINTS | KNTC1 CENPL PSMC4 PSMD5 PPP2CA PPP2CB CCNA1 PSME3 ANAPC5 DYNC1H1 | 2.17e-04 | 291 | 122 | 10 | M16647 |
| Pathway | REACTOME_AMPLIFICATION_OF_SIGNAL_FROM_THE_KINETOCHORES | 2.28e-04 | 100 | 122 | 6 | MM14561 | |
| Pathway | REACTOME_M_PHASE | KNTC1 OFD1 CENPL SMC4 PSMC4 PSMD5 TUBGCP2 PPP2CA PPP2CB PSME3 ANAPC5 DYNC1H1 | 2.64e-04 | 417 | 122 | 12 | M27662 |
| Pathway | REACTOME_G1_S_TRANSITION | 2.82e-04 | 104 | 122 | 6 | MM15376 | |
| Pathway | REACTOME_MITOTIC_G1_PHASE_AND_G1_S_TRANSITION | 3.11e-04 | 149 | 122 | 7 | M848 | |
| Pathway | REACTOME_CELL_CYCLE | KNTC1 OFD1 CENPL RBL1 SMC4 PSMC4 PSMD5 TUBGCP2 PPP2CA PPP2CB FBXL7 BRCA2 CCNA1 PSME3 ANAPC5 DYNC1H1 | 3.15e-04 | 694 | 122 | 16 | M543 |
| Pathway | REACTOME_CDK_MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6 | 3.69e-04 | 71 | 122 | 5 | MM15370 | |
| Pathway | REACTOME_MITOTIC_PROMETAPHASE | 3.94e-04 | 204 | 122 | 8 | M4217 | |
| Pathway | REACTOME_MITOTIC_SPINDLE_CHECKPOINT | 4.01e-04 | 111 | 122 | 6 | M27673 | |
| Pathway | REACTOME_ADAPTIVE_IMMUNE_SYSTEM | UBR1 UBR4 PSMC4 RNF213 PSMD5 KLHL41 ITPR3 KLHL3 PPP2CA PPP2CB FBXL7 PSME3 UBE3C ANAPC5 DYNC1H1 FBXO15 | 4.66e-04 | 719 | 122 | 16 | MM14540 |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | RALGAPA1 KNTC1 SEMA4F CENPL DOCK11 CFTR CPD CHN1 CHN2 ARPC3 PLEKHG1 PPP2CA PPP2CB PLEKHG3 ARHGEF4 DYNC1H1 | 4.73e-04 | 720 | 122 | 16 | M41838 |
| Pathway | REACTOME_ACTIVATION_OF_APC_C_AND_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS | 5.37e-04 | 77 | 122 | 5 | MM14692 | |
| Pathway | REACTOME_DEGRADATION_OF_BETA_CATENIN_BY_THE_DESTRUCTION_COMPLEX | 6.05e-04 | 79 | 122 | 5 | MM14754 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CONDENSIN_LOADING | 6.47e-04 | 20 | 122 | 3 | M47876 | |
| Pathway | WP_RETT_SYNDROME | 7.74e-04 | 48 | 122 | 4 | M39759 | |
| Pathway | REACTOME_NEDDYLATION | 7.75e-04 | 226 | 122 | 8 | MM15543 | |
| Pathway | REACTOME_DEGRADATION_OF_BETA_CATENIN_BY_THE_DESTRUCTION_COMPLEX | 8.44e-04 | 85 | 122 | 5 | M27079 | |
| Pathway | REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION | 8.88e-04 | 129 | 122 | 6 | MM14894 | |
| Pathway | REACTOME_APC_C_MEDIATED_DEGRADATION_OF_CELL_CYCLE_PROTEINS | 9.38e-04 | 87 | 122 | 5 | MM14677 | |
| Pathway | REACTOME_APC_C_MEDIATED_DEGRADATION_OF_CELL_CYCLE_PROTEINS | 9.88e-04 | 88 | 122 | 5 | M29582 | |
| Pathway | BIOCARTA_P35ALZHEIMERS_PATHWAY | 1.09e-03 | 6 | 122 | 2 | MM1381 | |
| Pathway | REACTOME_SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE | 1.09e-03 | 90 | 122 | 5 | MM15371 | |
| Pathway | REACTOME_SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE | 1.21e-03 | 92 | 122 | 5 | M27666 | |
| Pathway | REACTOME_CYCLIN_A_B1_B2_ASSOCIATED_EVENTS_DURING_G2_M_TRANSITION | 1.27e-03 | 25 | 122 | 3 | M808 | |
| Pathway | REACTOME_CYCLIN_A_B1_B2_ASSOCIATED_EVENTS_DURING_G2_M_TRANSITION | 1.27e-03 | 25 | 122 | 3 | MM15379 | |
| Pathway | REACTOME_NEDDYLATION | 1.30e-03 | 245 | 122 | 8 | M27822 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_FORMINS | 1.41e-03 | 141 | 122 | 6 | MM15266 | |
| Pathway | REACTOME_WAX_AND_PLASMALOGEN_BIOSYNTHESIS | 1.52e-03 | 7 | 122 | 2 | M27730 | |
| Pathway | REACTOME_PP2A_MEDIATED_DEPHOSPHORYLATION_OF_KEY_METABOLIC_FACTORS | 1.52e-03 | 7 | 122 | 2 | M26992 | |
| Pathway | REACTOME_SCF_SKP2_MEDIATED_DEGRADATION_OF_P27_P21 | 1.58e-03 | 58 | 122 | 4 | MM14715 | |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | SIN3B DOCK11 UBR4 TUBGCP2 GDI2 MAP3K5 SEPTIN2 PPP2CA PHKG1 CCM2 SCN8A TRMT1L EIF3J TRAPPC9 HTT STK25 | 5.45e-09 | 475 | 183 | 16 | 31040226 |
| Pubmed | ATP5PB KNTC1 KIF13B MACC1 PCDHGA11 PCDHGA10 PCDHGA7 PCDHGA1 ADAM7 U2SURP UBR4 ASH1L RGPD1 SMC4 TEX10 MIPOL1 PPP2CA PPP2CB SCN4A SMARCA1 MTTP EIF2AK4 ARHGEF4 ATP1A2 CADPS2 FBXO15 | 4.49e-08 | 1442 | 183 | 26 | 35575683 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | ATP5PB IARS1 CAPN1 UBR4 ASH1L PSMC4 PSMD5 NIBAN2 GDI2 PGD ARPC3 EPG5 SEPTIN2 NBAS SCN8A PCNX1 PSME3 MYO16 DYNC1H1 | 6.17e-08 | 807 | 183 | 19 | 30575818 |
| Pubmed | A directed protein interaction network for investigating intracellular signal transduction. | UBR1 DIABLO RBL1 RGS19 ATG13 SLC25A33 UBR4 RABAC1 EXT2 CHN1 GDI1 ARPC3 RXRG SEPTIN2 PPP2CB NUDT5 NOMO2 RIPOR1 ANAPC5 CCDC136 SNX5 STK25 | 1.34e-07 | 1124 | 183 | 22 | 21900206 |
| Pubmed | 1.43e-07 | 3 | 183 | 3 | 36011023 | ||
| Pubmed | Silencing of nodal modulator 1 inhibits the differentiation of P19 cells into cardiomyocytes. | 1.43e-07 | 3 | 183 | 3 | 25576386 | |
| Pubmed | ATP5PB OFD1 IARS1 UBR4 RABAC1 PSMC4 RNF213 IRF4 CPD EXT2 AGPS TUBGCP2 IFI16 ARPC3 NOMO1 ITPR3 NBAS PIGT PSME3 DYNC1H1 GNPAT PSD4 | 2.57e-07 | 1168 | 183 | 22 | 19946888 | |
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | IARS1 UBR4 SMC4 TRRAP GDI1 ARPC3 NOMO1 SEPTIN2 NOMO2 DYNC1H1 NOMO3 HTT | 3.26e-07 | 344 | 183 | 12 | 30333137 |
| Pubmed | Establishment of a conditional Nomo1 mouse model by CRISPR/Cas9 technology. | 5.71e-07 | 4 | 183 | 3 | 31833031 | |
| Pubmed | 5.71e-07 | 4 | 183 | 3 | 9267806 | ||
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | KNTC1 DIABLO IARS1 CAPN1 UBR4 SMC4 PSMC4 PSMD5 NIBAN2 GDI1 GDI2 PGD ARPC3 SEPTIN2 PPP2CA PPP2CB NUDT5 RIPOR1 PSME3 UBE3C EIF3J DYNC1H1 HTT SNX5 | 7.68e-07 | 1455 | 183 | 24 | 22863883 |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | KIF13B ERCC2 EMC1 CAPN1 UBR4 SMC4 PSMC4 PSMD5 AGPS TRRAP ARPC3 NBAS PPP2CB SMARCA1 ATP1A2 DYNC1H1 | 1.13e-06 | 704 | 183 | 16 | 29955894 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | SEMA4F ERCC2 OFD1 SZT2 UBR4 CFAP43 TRRAP MAP3K5 ITPR3 PLEKHG1 ZGPAT PPP2CB SCN8A PCNX1 RIPOR1 ARHGEF4 UBE3C TRAPPC9 DYNC1H1 HTT | 1.72e-06 | 1105 | 183 | 20 | 35748872 |
| Pubmed | Large-scale identification of c-MYC-associated proteins using a combined TAP/MudPIT approach. | 1.96e-06 | 211 | 183 | 9 | 17314511 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | KIF13B OFD1 DIABLO RBL1 IARS1 SMC4 PSMC4 GDI1 ARPC3 NOMO1 MIPOL1 PPP2CB PIGT CCNYL1 NUDT5 ZMYND10 PKD2 TRAPPC4 RIPOR1 MORC3 TRAPPC9 DYNC1H1 | 1.98e-06 | 1321 | 183 | 22 | 27173435 |
| Pubmed | Interpreting cancer genomes using systematic host network perturbations by tumour virus proteins. | RBL1 UBR4 RABAC1 PSMC4 FAM200A SQOR S1PR3 SLC5A3 MIPOL1 ZGPAT PIGT ZMYND10 PKD2 | 2.74e-06 | 499 | 183 | 13 | 22810586 |
| Pubmed | ATP5PB EMC1 IARS1 CAPN1 UBR4 RNF213 AGPS PPP2CB PSME3 EIF3J TRBC1 DYNC1H1 | 6.18e-06 | 457 | 183 | 12 | 22190034 | |
| Pubmed | Nicalin and its binding partner Nomo are novel Nodal signaling antagonists. | 7.87e-06 | 8 | 183 | 3 | 15257293 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | SEMA4F SIN3B DNAH3 DOCK11 IARS1 UBR4 SMC4 RNF213 AGPS CHN1 MIPOL1 FREM2 FBXL7 SCN8A DYNC1H1 | 9.15e-06 | 736 | 183 | 15 | 29676528 |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | ERCC2 EMC1 IARS1 U2SURP UBR4 RGPD1 SMC4 PSMC4 GDI2 ARPC3 NOMO1 PPP2CB NOMO2 CSTF1 NUB1 PSME3 UBE3C DYNC1H1 NOMO3 STK25 | 1.16e-05 | 1257 | 183 | 20 | 37317656 |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | UBR1 SIN3B DIABLO IARS1 CAPN1 UBR4 SMC4 PSMC4 RNF213 NIBAN2 AGPS GDI1 GDI2 PGD SEPTIN2 PPP2CA PPP2CB NUDT5 RMDN1 PSME3 EIF3J | 1.17e-05 | 1367 | 183 | 21 | 32687490 |
| Pubmed | Substrate-driven assembly of a translocon for multipass membrane proteins. | 1.18e-05 | 9 | 183 | 3 | 36261522 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | RALGAPA1 PHYKPL FOLH1 ATG13 CAPN1 ASH1L RNF213 CPD BTBD9 TRRAP CCNY MIPOL1 PLEKHG3 PKD2 RIPOR1 EIF2AK4 ARHGEF4 UBE3C TSEN15 TRAPPC9 HTT FRMD3 | 1.31e-05 | 1489 | 183 | 22 | 28611215 |
| Pubmed | CAPN1 PGD NOMO1 ZGPAT PPP2CA ART4 NOMO2 TSEN15 CCDC136 NOMO3 | 1.69e-05 | 347 | 183 | 10 | 15231747 | |
| Pubmed | 2.10e-05 | 63 | 183 | 5 | 31266804 | ||
| Pubmed | ERCC2 EMC1 SZT2 TUBGCP2 NOMO1 PPP2CA PPP2CB BRCA2 NOMO2 SMARCA1 UBE3C NOMO3 STK25 | 2.17e-05 | 606 | 183 | 13 | 36538041 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | ATP5PB KNTC1 EMC1 DIABLO IARS1 U2SURP UBR4 SMC4 PSMC4 AGPS GRM1 GDI2 PGD NOMO1 SEPTIN2 PPP2CA SMARCA1 CSTF1 PSME3 UBE3C DYNC1H1 | 2.17e-05 | 1425 | 183 | 21 | 30948266 |
| Pubmed | ATP5PB SIN3B NR2C2 OFD1 DIABLO IARS1 UBR4 RGPD1 PSMC4 IRF4 TEX10 TRRAP ARPC3 PPP2CA SMARCA1 CSTF1 PSME3 TRMT1L TRAPPC9 DYNC1H1 CPEB1 | 2.26e-05 | 1429 | 183 | 21 | 35140242 | |
| Pubmed | An ER translocon for multi-pass membrane protein biogenesis. | 2.29e-05 | 11 | 183 | 3 | 32820719 | |
| Pubmed | ATP5PB KNTC1 EMC1 UBR4 SMC4 PSMC4 RNF213 TUBGCP2 IFI16 ARPC3 ITPR3 NBAS PIGT PLEKHG3 TRAPPC4 PSME3 TRMT1L UBE3C EIF3J TRAPPC9 DYNC1H1 | 2.53e-05 | 1440 | 183 | 21 | 30833792 | |
| Pubmed | Autoubiquitination of the 26S proteasome on Rpn13 regulates breakdown of ubiquitin conjugates. | 2.63e-05 | 66 | 183 | 5 | 24811749 | |
| Pubmed | Activation of SV40 DNA replication in vitro by cellular protein phosphatase 2A. | 2.75e-05 | 2 | 183 | 2 | 2555176 | |
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 26974309 | ||
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 27493027 | ||
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 11751260 | ||
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 31912442 | ||
| Pubmed | Hydrophobic pore gates regulate ion permeation in polycystic kidney disease 2 and 2L1 channels. | 2.75e-05 | 2 | 183 | 2 | 29899465 | |
| Pubmed | PRA1 inhibits the extraction of membrane-bound rab GTPase by GDI1. | 2.75e-05 | 2 | 183 | 2 | 10751420 | |
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 20408813 | ||
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 19036965 | ||
| Pubmed | The proteasome activator REGγ accelerates cardiac hypertrophy by declining PP2Acα-SOD2 pathway. | 2.75e-05 | 2 | 183 | 2 | 32424140 | |
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 20663872 | ||
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 7585614 | ||
| Pubmed | Impaired membrane traffic in defective ether lipid biosynthesis. | 2.75e-05 | 2 | 183 | 2 | 11152660 | |
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 11113010 | ||
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 19646509 | ||
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 21990100 | ||
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 38423356 | ||
| Pubmed | Identification of NUB1 as a suppressor of mutant Huntington toxicity via enhanced protein clearance. | 2.75e-05 | 2 | 183 | 2 | 23525043 | |
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 10543450 | ||
| Pubmed | Prognostic significance of serum chemerin levels in patients with non-small cell lung cancer. | 2.75e-05 | 2 | 183 | 2 | 28160556 | |
| Pubmed | Protein phosphatase 2A in the healthy and failing heart: New insights and therapeutic opportunities. | 2.75e-05 | 2 | 183 | 2 | 34902541 | |
| Pubmed | Human liver phosphatase 2A: cDNA and amino acid sequence of two catalytic subunit isotypes. | 2.75e-05 | 2 | 183 | 2 | 2837763 | |
| Pubmed | Structure and transcriptional regulation of protein phosphatase 2A catalytic subunit genes. | 2.75e-05 | 2 | 183 | 2 | 1846293 | |
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 20557290 | ||
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 24801688 | ||
| Pubmed | PP2A regulates kinetochore-microtubule attachment during meiosis I in oocyte. | 2.75e-05 | 2 | 183 | 2 | 27096707 | |
| Pubmed | CFTR and PC2, partners in the primary cilia in autosomal dominant polycystic kidney disease. | 2.75e-05 | 2 | 183 | 2 | 37519231 | |
| Pubmed | Differential roles of ASK1 and TAK1 in Helicobacter pylori-induced cellular responses. | 2.75e-05 | 2 | 183 | 2 | 24082073 | |
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 10215861 | ||
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | ERCC2 RBL1 ATG13 PSMD5 TEX10 TRRAP NOMO1 PPP2CA PPP2CB NOMO2 EIF2AK4 PSME3 EIF3J ANAPC5 NOMO3 STK25 | 2.80e-05 | 910 | 183 | 16 | 36736316 |
| Pubmed | Mindbomb 1, an E3 ubiquitin ligase, forms a complex with RYK to activate Wnt/β-catenin signaling. | 2.83e-05 | 67 | 183 | 5 | 21875946 | |
| Pubmed | 3.04e-05 | 34 | 183 | 4 | 25505242 | ||
| Pubmed | 3.04e-05 | 12 | 183 | 3 | 11259605 | ||
| Pubmed | MRG15 is a novel PALB2-interacting factor involved in homologous recombination. | 3.04e-05 | 12 | 183 | 3 | 19553677 | |
| Pubmed | SIN3B MACC1 ERCC2 EMC1 RGS19 SMC4 TEX10 TRRAP SQOR ARPC3 NOMO1 EFR3A ZGPAT PPP2CA PIGT PTCD1 PLEKHG3 CSTF1 TRMT1L EIF3J ANAPC5 | 4.43e-05 | 1497 | 183 | 21 | 31527615 | |
| Pubmed | 4.76e-05 | 38 | 183 | 4 | 28218735 | ||
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | OFD1 ATG13 RGPD1 CPD TUBGCP2 GDI2 ARPC3 MIPOL1 PLEKHG1 NUDT5 BRCA2 NOMO2 UBE3C MORC3 DYNC1H1 | 5.01e-05 | 853 | 183 | 15 | 28718761 |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | ATP5PB KNTC1 EMC1 IARS1 UBR4 SMC4 PSMC4 SNRK EXT2 TRRAP GDI1 ARPC3 CCNY SEPTIN2 PPP2CB CCNA1 PSME3 DYNC1H1 STK25 | 5.17e-05 | 1284 | 183 | 19 | 17353931 |
| Pubmed | KIF13B SIN3B DOCK11 UBR4 RGPD1 BTBD9 GRM1 TEX10 GDI1 GDI2 ARPC3 MAP3K5 SEPTIN2 PPP2CB CDH10 DYNC1H1 | 5.47e-05 | 963 | 183 | 16 | 28671696 | |
| Pubmed | HAPSTR1 localizes HUWE1 to the nucleus to limit stress signaling pathways. | ATP5PB IARS1 CAPN1 PSMC4 AGPS SEPTIN2 PPP2CB NOMO2 PSME3 ANAPC5 DYNC1H1 GNPAT | 5.49e-05 | 571 | 183 | 12 | 37167062 |
| Pubmed | DOCK11 IARS1 UBR4 SMC4 PSMC4 SEPTIN2 PPP2CB PSME3 DYNC1H1 STK25 | 5.50e-05 | 399 | 183 | 10 | 37536630 | |
| Pubmed | ERCC2 EMC1 IARS1 U2SURP UBR4 SMC4 PSMC4 CPD EXT2 AGPS TRRAP PGD PIGT NOMO2 CSTF1 TRMT1L UBE3C DYNC1H1 STK25 | 5.91e-05 | 1297 | 183 | 19 | 33545068 | |
| Pubmed | 6.22e-05 | 15 | 183 | 3 | 23515096 | ||
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 7.18e-05 | 332 | 183 | 9 | 32786267 | |
| Pubmed | 8.23e-05 | 3 | 183 | 2 | 24703837 | ||
| Pubmed | Serine 58 of 14-3-3zeta is a molecular switch regulating ASK1 and oxidant stress-induced cell death. | 8.23e-05 | 3 | 183 | 2 | 19451227 | |
| Pubmed | Stratification for smoking in case-cohort studies of genetic polymorphisms and lung cancer. | 8.23e-05 | 3 | 183 | 2 | 18778871 | |
| Pubmed | 8.23e-05 | 3 | 183 | 2 | 26240314 | ||
| Pubmed | 8.23e-05 | 3 | 183 | 2 | 22184064 | ||
| Pubmed | 8.23e-05 | 3 | 183 | 2 | 7510677 | ||
| Pubmed | 8.23e-05 | 3 | 183 | 2 | 18249095 | ||
| Pubmed | α2-Chimaerin is essential for neural stem cell homeostasis in mouse adult neurogenesis. | 8.23e-05 | 3 | 183 | 2 | 31209021 | |
| Pubmed | CCNYL1, but Not CCNY, Cooperates with CDK16 to Regulate Spermatogenesis in Mouse. | 8.23e-05 | 3 | 183 | 2 | 26305884 | |
| Pubmed | 8.23e-05 | 3 | 183 | 2 | 22407040 | ||
| Pubmed | 8.23e-05 | 3 | 183 | 2 | 11954550 | ||
| Pubmed | 8.23e-05 | 3 | 183 | 2 | 9677412 | ||
| Pubmed | 8.23e-05 | 3 | 183 | 2 | 22520513 | ||
| Pubmed | 8.23e-05 | 3 | 183 | 2 | 34662438 | ||
| Pubmed | 8.23e-05 | 3 | 183 | 2 | 22782892 | ||
| Pubmed | 8.23e-05 | 3 | 183 | 2 | 30391931 | ||
| Pubmed | The catalytic subunit of protein phosphatase 2A is carboxyl-methylated in vivo. | 8.23e-05 | 3 | 183 | 2 | 8206937 | |
| Pubmed | Polycystin-2 interacts with troponin I, an angiogenesis inhibitor. | 8.23e-05 | 3 | 183 | 2 | 12525172 | |
| Pubmed | 8.23e-05 | 3 | 183 | 2 | 28434254 | ||
| Pubmed | EphA4-dependent axon guidance is mediated by the RacGAP alpha2-chimaerin. | 8.23e-05 | 3 | 183 | 2 | 17785182 | |
| Pubmed | 8.23e-05 | 3 | 183 | 2 | 25114233 | ||
| Pubmed | 8.23e-05 | 3 | 183 | 2 | 7543319 | ||
| Pubmed | Polycystin-2 expression and function in adult mouse lacrimal acinar cells. | 8.23e-05 | 3 | 183 | 2 | 21508103 | |
| Pubmed | 8.23e-05 | 3 | 183 | 2 | 7513052 | ||
| Pubmed | 8.23e-05 | 3 | 183 | 2 | 17761535 | ||
| Interaction | PSMC5 interactions | NR2C2 EMC1 CFTR UBR4 SMC4 PSMC4 PSMD5 GRM1 MAP3K5 PPP2CB CFAP206 NUB1 PSME3 UBE3C CCDC136 DYNC1H1 HTT | 1.59e-06 | 484 | 179 | 17 | int:PSMC5 |
| Interaction | P2RY6 interactions | ATP5PB KNTC1 EMC1 CFTR UBR4 SMC4 PSMC4 TUBGCP2 MAP3K5 ITPR3 NBAS PIGT UBE3C EIF3J | 9.29e-06 | 385 | 179 | 14 | int:P2RY6 |
| Interaction | CRYL1 interactions | 1.01e-05 | 56 | 179 | 6 | int:CRYL1 | |
| Interaction | PSMD3 interactions | NR2C2 ATG13 CFTR PSMC4 PSMD5 IFI16 TRRAP PPP2CA BRCA2 PSME3 UBE3C DYNC1H1 HTT NAA16 | 1.07e-05 | 390 | 179 | 14 | int:PSMD3 |
| Cytoband | 5q31 | 1.03e-04 | 115 | 183 | 5 | 5q31 | |
| Cytoband | 1q25.2 | 2.58e-04 | 31 | 183 | 3 | 1q25.2 | |
| GeneFamily | Protein phosphatase catalytic subunits|STRIPAK complex | 2.85e-04 | 20 | 118 | 3 | 1371 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 4.08e-04 | 206 | 118 | 7 | 682 | |
| GeneFamily | Cyclins | 7.88e-04 | 28 | 118 | 3 | 473 | |
| GeneFamily | Clustered protocadherins | 8.10e-04 | 64 | 118 | 4 | 20 | |
| GeneFamily | Ubiquitin protein ligase E3 component n-recognins | 8.68e-04 | 7 | 118 | 2 | 785 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 1.48e-03 | 9 | 118 | 2 | 1203 | |
| GeneFamily | Proteasome | 2.77e-03 | 43 | 118 | 3 | 690 | |
| GeneFamily | Protein phosphatase catalytic subunits|EF-hand domain containing | 3.14e-03 | 13 | 118 | 2 | 693 | |
| GeneFamily | Trafficking protein particle complex | 3.65e-03 | 14 | 118 | 2 | 772 | |
| Coexpression | GSE20727_CTRL_VS_H2O2_TREATED_DC_UP | SEMA4F MANBA PLEKHG7 IFI16 CHN2 CCNY EPG5 PLEKHG1 RIPOR1 ARMH3 TRAPPC9 | 1.50e-07 | 198 | 182 | 11 | M9245 |
| Coexpression | GSE10147_IL3_VS_IL3_AND_CPG_STIM_PDC_DN | CATSPERD PSMD5 TUBGCP2 SQOR ANGPTL1 NOMO1 KLHL3 CSTF1 TXNDC16 | 2.43e-06 | 165 | 182 | 9 | M353 |
| Coexpression | GSE29164_CD8_TCELL_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY7_UP | 1.16e-05 | 200 | 182 | 9 | M8500 | |
| ToppCell | Control-Epithelial_cells-Airway_club|Control / group, cell type (main and fine annotations) | 6.44e-08 | 181 | 183 | 9 | c755d23dd9aabc717dc73e2b3fa99a1f751e6507 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.02e-07 | 191 | 183 | 9 | 60ff989fe99d243a3d52955223680cdd1f1917a4 | |
| ToppCell | IPF-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | DNAH3 CATSPERD CFAP43 CHN2 CFAP54 TMEM232 ZMYND10 CFAP206 LRRC23 | 1.11e-07 | 193 | 183 | 9 | ad58f5080e0ba65c845056ea6b79037b636e9c64 |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor2_(4)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.17e-07 | 194 | 183 | 9 | 6b286992d4bb56013c0ea5a7601d3476d806175a | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.17e-07 | 194 | 183 | 9 | f95c8dc242c9aebcadfe61b1ed033349cb7e5a88 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.33e-07 | 197 | 183 | 9 | 749e0e332644543cbdf2ee38c2b301ce0a019a7f | |
| ToppCell | proximal-Epithelial-Ciliated|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | DNAH3 CATSPERD CFAP43 CFAP54 TMEM232 ZMYND10 CFAP206 FBXO15 LRRC23 | 1.45e-07 | 199 | 183 | 9 | 9700f06e51ddca85e482b4f9bd4a79bfcd3cfb76 |
| ToppCell | proximal-3-Epithelial-Ciliated|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | DNAH3 CATSPERD CFAP43 CFAP54 TMEM232 ZMYND10 CFAP206 FBXO15 LRRC23 | 1.45e-07 | 199 | 183 | 9 | 1188afad6fd5f01f9aeba225f611f38b237dd2c9 |
| ToppCell | proximal-Epithelial-Ciliated-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | DNAH3 CATSPERD CFAP43 CFAP54 TMEM232 ZMYND10 CFAP206 FBXO15 LRRC23 | 1.45e-07 | 199 | 183 | 9 | 2e8ace105c4e2405baa06d953e52888b54e2d055 |
| ToppCell | facs-Trachea-nan-24m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.13e-07 | 173 | 183 | 8 | 27ae126c720f20d1fe116abbcd358e4cff8baf6b | |
| ToppCell | facs-Trachea-24m-Epithelial-airway_epithelial-tracheobronchial_ciliated_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.40e-07 | 174 | 183 | 8 | f1510b0f7771936adf29ae3572feab55db31832b | |
| ToppCell | facs-Trachea-24m-Epithelial-airway_epithelial-tracheobronchial_ciliated_cell-ciliated_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.40e-07 | 174 | 183 | 8 | 5d5d2fc60afff47f997751e8e9ca1367a22d19ec | |
| ToppCell | Ciliated_cells-B-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | DNAH3 CATSPERD PLEKHG7 CFAP43 CFAP54 TMEM232 ZMYND10 CFAP206 | 1.02e-06 | 185 | 183 | 8 | f012c243343e1d1956db19b34d062e9b13de2b2a |
| ToppCell | Ciliated_cells-B-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 1.06e-06 | 186 | 183 | 8 | f72267d533fd0c5280d9741ceee3dd116300a7e4 | |
| ToppCell | Ciliated_cells-B-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 1.10e-06 | 187 | 183 | 8 | bc1f33f332ac939c2425f510173430ca2ba0c3ee | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Ciliated_1|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | DNAH3 CATSPERD PLEKHG7 CFAP43 CFAP54 TMEM232 ZMYND10 CFAP206 | 1.19e-06 | 189 | 183 | 8 | dc440015949a768188c67661b6be63b1ead1a0f0 |
| ToppCell | COVID-19-lung-Ciliated|lung / Disease (COVID-19 only), tissue and cell type | 1.19e-06 | 189 | 183 | 8 | 27329c4661aebabd19fac7fe5dca263fe99d76f3 | |
| ToppCell | E18.5-Epithelial-Epithelial_Airway|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.24e-06 | 190 | 183 | 8 | 5c012935ea5e35a2d0d08ea7dc04ffbe3c2a10ac | |
| ToppCell | E18.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.29e-06 | 191 | 183 | 8 | acd844b477a069b2dcf07b2998e1b5c87dc0eb94 | |
| ToppCell | Bronchial_Biopsy-Epithelial-Ciliated_1|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.34e-06 | 192 | 183 | 8 | be592e661367affced9ebe80849b466e6adb3a34 | |
| ToppCell | Control-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 1.40e-06 | 193 | 183 | 8 | 0e37d454f3735edd936ee9a5f5f516ac3aad400e | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | CATSPERD CFAP43 CFAP54 TMEM232 ZMYND10 CFAP206 FBXO15 LRRC23 | 1.45e-06 | 194 | 183 | 8 | a46238514bca920c3e3713d23c18ba24a09e2a29 |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-B-B_plasma|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.69e-06 | 198 | 183 | 8 | 567fcf882c8612356946240843525b786f3c8dbe | |
| ToppCell | distal-Epithelial-Ciliated-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.75e-06 | 199 | 183 | 8 | 2de1fe124737a6cca4b3805ab3056f9d9d7c16c7 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_ciliated-Ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.82e-06 | 200 | 183 | 8 | 926a7ea94b5908aebf103893ea83ce9d25285b65 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Ciliated|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.82e-06 | 200 | 183 | 8 | f1a49bc818054fb0734d3b84725ee6487b034567 | |
| ToppCell | Parenchyma_COVID-19-Epithelial-TX-Ciliated|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 1.82e-06 | 200 | 183 | 8 | d7ae09189cf0b7e2f7e7fc6b0921975b75aa7d62 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.82e-06 | 200 | 183 | 8 | 06ce6e03498ba38ef6a06eaf2731e3b2eeda59eb | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Ciliated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.82e-06 | 200 | 183 | 8 | cf59110547cc66b5f4a2999735336b0309ba9b0d | |
| ToppCell | PBMC-Control-cDC_2|Control / Compartment, Disease Groups and Clusters | 3.37e-06 | 153 | 183 | 7 | 4ee37266b0054f276c7a73ab9220f681b9d74c71 | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells-Ciliated|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.52e-06 | 154 | 183 | 7 | 9ca71d440c4f87781e6525b8141e7d8d470b6a8e | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.52e-06 | 154 | 183 | 7 | 58072ce422d09f2de602580325eaac6c4ec6c136 | |
| ToppCell | lung-Ciliated_Epithelia|lung / shred on tissue and cell subclass | 6.01e-06 | 167 | 183 | 7 | 26cf1cfa58ee74794449a87eb19cd896e1ec8892 | |
| ToppCell | 15-Distal-Epithelial-Multiciliated_precursor|Distal / Age, Tissue, Lineage and Cell class | 6.01e-06 | 167 | 183 | 7 | 442ea71a581ed5a547a214132b9f1b0243fd0895 | |
| ToppCell | 15-Distal-Epithelial-Multiciliated_cell|Distal / Age, Tissue, Lineage and Cell class | 6.50e-06 | 169 | 183 | 7 | 425d89ab69e9f9eb3df84056676423e390cc6ab1 | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.57e-06 | 173 | 183 | 7 | c3762655caa79ac4879876f470d32578a3c93b01 | |
| ToppCell | Ciliated_cells-B-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 8.79e-06 | 177 | 183 | 7 | c38138fb5ad9766c2d240811210c854338cd612e | |
| ToppCell | T_cells-ISG-high_CD4+_T_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 9.45e-06 | 179 | 183 | 7 | af35ef8a7768cee0c2af0590e5bec35cee6a4714 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.45e-06 | 179 | 183 | 7 | 815b959ce8721c5ded70c0ca6e318dafc691746e | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.45e-06 | 179 | 183 | 7 | 5e5f1cdf4aa66868d45b74ba91e20e848a3cbaff | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.02e-05 | 181 | 183 | 7 | dfce05bd472f67e6e2bb60ebd6fd34f0a9aeeca6 | |
| ToppCell | Control-Epithelial_cells-Airway_ciliated|Control / group, cell type (main and fine annotations) | 1.05e-05 | 182 | 183 | 7 | fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f | |
| ToppCell | Ciliated_cells-A-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 1.17e-05 | 185 | 183 | 7 | d77ca57b02125a3a57a37f4aed20c89803b7d551 | |
| ToppCell | Ciliated_cells-B-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 1.26e-05 | 187 | 183 | 7 | 6fa38dbccca36bc7a4fef46de74c6688f599f421 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.26e-05 | 187 | 183 | 7 | 9e10ed56090d82589bc457788282f664b70ace4b | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.30e-05 | 188 | 183 | 7 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | COVID-19-lung-Ciliated|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.35e-05 | 189 | 183 | 7 | a2da5debd10f27b1280b40141ef0bfef007cc72c | |
| ToppCell | PND01-Epithelial-Epithelial_Airway|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.35e-05 | 189 | 183 | 7 | 38cde34295566a4ecaf7d0a81c5a192cf17d0459 | |
| ToppCell | Ciliated|World / shred by cell class for parenchyma | 1.35e-05 | 189 | 183 | 7 | 711181ca3b9102fb155168b646b0a9b09ff215b2 | |
| ToppCell | E16.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.44e-05 | 191 | 183 | 7 | 1e21de183a9c09cfb6aad3f9b948087fb6bad061 | |
| ToppCell | PND01-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.44e-05 | 191 | 183 | 7 | 96483adb97c81208aa513782550acd8a08b63866 | |
| ToppCell | E16.5-Epithelial-Epithelial_Airway|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.49e-05 | 192 | 183 | 7 | bb7eb51bc079acacde42d8e55ba06d03eba2ea28 | |
| ToppCell | E16.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Deuterosomal|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.49e-05 | 192 | 183 | 7 | a50a6279371b3be682e334082637b7ab76b9a6e5 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.54e-05 | 193 | 183 | 7 | b25cdca3a1e381784ae48ca73c51cbb6ac62b811 | |
| ToppCell | Bronchial_Biopsy-Epithelial-Ciliated_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.54e-05 | 193 | 183 | 7 | 0b62a6ddd7c42efd9f39781971d1438501e1fa8d | |
| ToppCell | ASK440-Epithelial-Ciliated|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.54e-05 | 193 | 183 | 7 | a0baa8be6f590b2031fede22be588715ae458e93 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.65e-05 | 195 | 183 | 7 | 0e763f36786515698b593e5c93f6a56619c1242d | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.65e-05 | 195 | 183 | 7 | 0fbba312e9ba9b70b4b814b67b6eb1f6544aaf6d | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.65e-05 | 195 | 183 | 7 | 581b04220587e1d5198b1abd6965965ace7803e7 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.65e-05 | 195 | 183 | 7 | 93b1559382a12cfb158aa5fac7386e38b4f87989 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.65e-05 | 195 | 183 | 7 | e22ca35bea06aa95ff2cc771632969f5e7229ffc | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.65e-05 | 195 | 183 | 7 | 9651ee03738226ee10e901f8b9ec6a417eb9c301 | |
| ToppCell | (05)_Ciliated|World / shred by cell type and Timepoint | 1.76e-05 | 197 | 183 | 7 | fee3cd16af8eea697cd64e8f64af505aaa2ac4b0 | |
| ToppCell | PSB-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.76e-05 | 197 | 183 | 7 | 6865f4831eb23794fb88a8649d48d497bbae3f44 | |
| ToppCell | COVID_vent-Lymphocytic-Plasma_cell-IgA_Plasmablast|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.76e-05 | 197 | 183 | 7 | 99fe44ef42c65d24fe64947fd5bf6d91b9a4b2c3 | |
| ToppCell | distal-3-Epithelial-Proximal_Ciliated|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.76e-05 | 197 | 183 | 7 | 15b4d1203943ce90a7083178d4a4284d9b323071 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.4|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.76e-05 | 197 | 183 | 7 | d83c61d2b5742e463122e1a98c7197a5b5b3d41b | |
| ToppCell | wk_08-11-Epithelial-Airway_epithelial_progenitor-epi-prox-progenitor_intermediate_|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.82e-05 | 198 | 183 | 7 | 1eb49b853a9e144e840c660060473fc7873f6478 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.82e-05 | 198 | 183 | 7 | 1847ce8c344c8a3e50f3cbbf758a38aba69f85b0 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.82e-05 | 198 | 183 | 7 | 5fc25b008a4d8d6bec83923a16f64dd9e1ff1f2d | |
| ToppCell | distal-Epithelial-Ciliated|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.88e-05 | 199 | 183 | 7 | 18ca031cfe702afb9bf94e03c0f3680c38e7599e | |
| ToppCell | distal-1-Epithelial-Ciliated|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.88e-05 | 199 | 183 | 7 | 4120e4a2bc05adebe1e1e9670ed7ea55142eb83d | |
| ToppCell | distal-3-Epithelial-Ciliated|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.88e-05 | 199 | 183 | 7 | 7e5f29f4ec1fea92f2c0064eea151d2d474ef904 | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-Ciliated|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 1.94e-05 | 200 | 183 | 7 | 9ae434c78e08adf95da49c85616e3ca72d1227bf | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial-Ciliated|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.94e-05 | 200 | 183 | 7 | 96701a4d57753f5ec0dd5c7550054bbcc946bc5f | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.94e-05 | 200 | 183 | 7 | 31d75c26055177d656df1fbb10b764cebd61e122 | |
| ToppCell | Biopsy_IPF-Epithelial-Ciliated|Biopsy_IPF / Sample group, Lineage and Cell type | 1.94e-05 | 200 | 183 | 7 | bb8c99156e547a8eb6599b6b6bc3c66bf77af7f8 | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_airway_ciliated|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.94e-05 | 200 | 183 | 7 | 5abd6d81e1cc354484ae693fcd708d78926e75b5 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.94e-05 | 200 | 183 | 7 | e1dce91c6c531bb212002a14705e496d77ad3490 | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.41e-05 | 148 | 183 | 6 | d61123f0c811287843d066b932b4a9ff09c07c5b | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Ciliated_cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.41e-05 | 148 | 183 | 6 | c8e93b87212f55774223caa385859c566fa1981f | |
| ToppCell | LPS-IL1RA-Epithelial_airway-Ciliated_cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.81e-05 | 151 | 183 | 6 | 81cf939ed4df9574fbfff265e109cb9f947d7e6e | |
| ToppCell | LPS-IL1RA-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.81e-05 | 151 | 183 | 6 | 9cbcbbc22965a9f0be8364e733d205dd64f2a533 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_4|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.81e-05 | 151 | 183 | 6 | 5d64655b6b09cc0a6d44629a31048b787a0916c5 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_PP_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.25e-05 | 154 | 183 | 6 | 2d98bb7a784fc3215e0d4a1670d662e5df4716c3 | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells-Ciliated|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.25e-05 | 154 | 183 | 6 | 4e3bc24043144143842627cacf6f90dda2228910 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_PP_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.25e-05 | 154 | 183 | 6 | 0dec222101530f1727184dbb7c03969d3884f111 | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.25e-05 | 154 | 183 | 6 | 7556a4b2b062da5ae7ec2bbb66e745e7662db628 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.41e-05 | 155 | 183 | 6 | 5f1e2195a6b831e1b636f5cc3a282ca423721822 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.41e-05 | 155 | 183 | 6 | 0944429459f642a1bcc56edc1ec28aaecde3e2dc | |
| ToppCell | TCGA-Stomach-Solid_Tissue_Normal-Stomach_normal_tissue-Stomach_normal_tissue-7|TCGA-Stomach / Sample_Type by Project: Shred V9 | 5.64e-05 | 162 | 183 | 6 | b115b5799137122bd60696f8ae2aebadad6cd044 | |
| ToppCell | Ciliated_cells-A-Donor_01|World / lung cells shred on cell class, cell subclass, sample id | 5.84e-05 | 163 | 183 | 6 | 43194c6127df1ce3d29242f719645de3c11fd7c0 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.04e-05 | 164 | 183 | 6 | e4d4c59aebe5cacd4ecdb907facd044dc82a831d | |
| ToppCell | E16.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Deuterosomal-Deuterosomal_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.04e-05 | 164 | 183 | 6 | d9531848105d606adedde65426177cf851140e31 | |
| ToppCell | Ciliated_cells-B-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 6.04e-05 | 164 | 183 | 6 | fd30c55d0d75ef8b9396435d836187168095152b | |
| ToppCell | Ciliated_cells-B-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 6.04e-05 | 164 | 183 | 6 | 0e9961acbb1d6c0089e6805ba6756736fa4d8bed | |
| ToppCell | Ciliated_cells-B-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 6.46e-05 | 166 | 183 | 6 | 4b1056aad8a99827835242b8ab0c7f2bb84471f1 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.68e-05 | 167 | 183 | 6 | 063ec29b32e40aaa138a691da3a79ee8eef0c2be | |
| ToppCell | NS-critical-d_0-4-Myeloid-Monocyte-derived_Macrophage|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.37e-05 | 170 | 183 | 6 | adf73bdc049d508f8873c22539db2ca92052a97b | |
| ToppCell | Ciliated_cells-A-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 7.37e-05 | 170 | 183 | 6 | 8b7ef1464ea589886b575ebad5447b085cbdcdba | |
| Disease | mental development measurement | 1.50e-05 | 25 | 179 | 4 | EFO_0008230 | |
| Disease | cerebral cavernous malformation (implicated_via_orthology) | 3.49e-05 | 11 | 179 | 3 | DOID:0060669 (implicated_via_orthology) | |
| Disease | Huntington Disease, Late Onset | 4.64e-05 | 12 | 179 | 3 | C0393574 | |
| Disease | Akinetic-Rigid Variant of Huntington Disease | 4.64e-05 | 12 | 179 | 3 | C0751207 | |
| Disease | Juvenile Huntington Disease | 4.64e-05 | 12 | 179 | 3 | C0751208 | |
| Disease | childhood trauma measurement, alcohol consumption measurement | 7.32e-05 | 71 | 179 | 5 | EFO_0007878, EFO_0007979 | |
| Disease | Chondrodysplasia Punctata, Rhizomelic | 1.09e-04 | 3 | 179 | 2 | C0282529 | |
| Disease | polycystic kidney disease 2 (implicated_via_orthology) | 1.09e-04 | 3 | 179 | 2 | DOID:0110859 (implicated_via_orthology) | |
| Disease | vaccenic acid measurement | 1.09e-04 | 3 | 179 | 2 | EFO_0007974 | |
| Disease | Huntington Disease | 1.40e-04 | 17 | 179 | 3 | C0020179 | |
| Disease | Hypokalemic periodic paralysis | 2.18e-04 | 4 | 179 | 2 | C0238358 | |
| Disease | cardiovascular system disease (is_implicated_in) | 2.69e-04 | 21 | 179 | 3 | DOID:1287 (is_implicated_in) | |
| Disease | Intellectual Disability | RALGAPA1 ASH1L TRRAP PPP2CA PTCHD1 SCN8A TRAPPC4 TSEN15 DYNC1H1 HTT | 4.28e-04 | 447 | 179 | 10 | C3714756 |
| Disease | allergic bronchopulmonary aspergillosis (is_implicated_in) | 5.40e-04 | 6 | 179 | 2 | DOID:13166 (is_implicated_in) | |
| Disease | oral mucosa leukoplakia (is_implicated_in) | 5.40e-04 | 6 | 179 | 2 | DOID:9655 (is_implicated_in) | |
| Disease | Familial benign neonatal epilepsy | 5.40e-04 | 6 | 179 | 2 | C0220669 | |
| Disease | cystic fibrosis (is_implicated_in) | 5.77e-04 | 27 | 179 | 3 | DOID:1485 (is_implicated_in) | |
| Disease | Microcephaly | 7.45e-04 | 67 | 179 | 4 | C0025958 | |
| Disease | wellbeing measurement, smoking behaviour measurement | 7.53e-04 | 7 | 179 | 2 | EFO_0005671, EFO_0007869 | |
| Disease | Headache, fasting blood glucose measurement | 7.53e-04 | 7 | 179 | 2 | EFO_0004465, HP_0002315 | |
| Disease | palmitoleic acid measurement | 7.53e-04 | 7 | 179 | 2 | EFO_0007973 | |
| Disease | glycosyl-N-(2-hydroxynervonoyl)-sphingosine (d18:1/24:1(2OH)) measurement | 1.00e-03 | 8 | 179 | 2 | EFO_0800533 | |
| Disease | intellectual disability (implicated_via_orthology) | 1.14e-03 | 75 | 179 | 4 | DOID:1059 (implicated_via_orthology) | |
| Disease | response to methylphenidate | 1.28e-03 | 9 | 179 | 2 | GO_0036271 | |
| Disease | Global developmental delay | 1.34e-03 | 133 | 179 | 5 | C0557874 | |
| Disease | medulloblastoma (is_implicated_in) | 1.59e-03 | 10 | 179 | 2 | DOID:0050902 (is_implicated_in) | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 1.59e-03 | 10 | 179 | 2 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 1.59e-03 | 10 | 179 | 2 | DOID:0080422 (implicated_via_orthology) | |
| Disease | 1-(1-enyl-palmitoyl)-2-palmitoleoyl-GPC (P-16:0/16:1) measurement | 1.59e-03 | 10 | 179 | 2 | EFO_0800464 | |
| Disease | attention deficit hyperactivity disorder, asthma | 1.59e-03 | 10 | 179 | 2 | EFO_0003888, MONDO_0004979 | |
| Disease | allergic conjunctivitis (is_marker_for) | 1.59e-03 | 10 | 179 | 2 | DOID:11204 (is_marker_for) | |
| Disease | Fanconi anemia (is_implicated_in) | 1.59e-03 | 10 | 179 | 2 | DOID:13636 (is_implicated_in) | |
| Disease | carotid plaque build | 1.73e-03 | 84 | 179 | 4 | EFO_0006501 | |
| Disease | ovary epithelial cancer (is_implicated_in) | 1.94e-03 | 11 | 179 | 2 | DOID:2152 (is_implicated_in) | |
| Disease | senile cataract (is_implicated_in) | 1.94e-03 | 11 | 179 | 2 | DOID:9669 (is_implicated_in) | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 2.32e-03 | 12 | 179 | 2 | DOID:0060170 (implicated_via_orthology) | |
| Disease | alcohol and nicotine codependence | 2.73e-03 | 13 | 179 | 2 | EFO_0004776 | |
| Disease | Mental Retardation, X-Linked Nonsyndromic | 2.73e-03 | 13 | 179 | 2 | C3501611 | |
| Disease | skin melanoma (is_implicated_in) | 3.17e-03 | 14 | 179 | 2 | DOID:8923 (is_implicated_in) | |
| Disease | autosomal dominant polycystic kidney disease (implicated_via_orthology) | 3.17e-03 | 14 | 179 | 2 | DOID:898 (implicated_via_orthology) | |
| Disease | age at last pregnancy measurement | 3.17e-03 | 14 | 179 | 2 | EFO_0009440 | |
| Disease | sulfate measurement | 3.17e-03 | 14 | 179 | 2 | EFO_0007864 | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 3.30e-03 | 49 | 179 | 3 | DOID:0060037 (implicated_via_orthology) | |
| Disease | Crohn Disease | 3.49e-03 | 50 | 179 | 3 | C0010346 | |
| Disease | lymphocyte count | FNIP2 MANBA OR5V1 PCDHGA11 PCDHGA10 PCDHGA7 RBL1 RGS19 PCDHGA1 OLFM4 PKD2L1 IRF4 ZMYND10 SLC17A9 RIPOR1 MORC3 HTT PSD4 | 3.57e-03 | 1464 | 179 | 18 | EFO_0004587 |
| Disease | X-21410 measurement | 4.15e-03 | 16 | 179 | 2 | EFO_0800813 | |
| Disease | level of Phosphatidylcholine (18:0_20:3) in blood serum | 4.15e-03 | 16 | 179 | 2 | OBA_2045093 | |
| Disease | melanoma | 4.17e-03 | 248 | 179 | 6 | C0025202 | |
| Disease | hair colour measurement | FOLH1 IRF4 CCNY EPG5 FREM2 PTCHD1 PCNX1 RASSF9 TMEM258 IP6K2 | 4.49e-03 | 615 | 179 | 10 | EFO_0007822 |
| Disease | acute lymphoblastic leukemia (is_implicated_in) | 4.57e-03 | 55 | 179 | 3 | DOID:9952 (is_implicated_in) | |
| Disease | Muscle hypotonia | 4.69e-03 | 17 | 179 | 2 | C0026827 | |
| Disease | perinatal necrotizing enterocolitis (biomarker_via_orthology) | 4.69e-03 | 17 | 179 | 2 | DOID:8677 (biomarker_via_orthology) | |
| Disease | Feeding difficulties | 5.25e-03 | 18 | 179 | 2 | C0232466 | |
| Disease | multiple myeloma (is_implicated_in) | 5.56e-03 | 59 | 179 | 3 | DOID:9538 (is_implicated_in) | |
| Disease | prostate cancer (is_implicated_in) | 5.70e-03 | 117 | 179 | 4 | DOID:10283 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ALLSSYLVAYRVAKE | 146 | P0CF97 | |
| KIIVLEIYEVSYVTL | 796 | Q9HCE0 | |
| LDLITIEKQILTGYY | 2491 | Q9NR48 | |
| IKVSYTVYNRLSLLL | 111 | O75143 | |
| ASEILDYYQKLLISL | 721 | Q8NDM7 | |
| ICSVIASLYYIIREL | 2066 | Q96N23 | |
| ISLARAVYKDADLYL | 556 | P13569 | |
| SLLLLVVDQKVYIYD | 106 | Q86XM0 | |
| SQVYIILYDAVTEKL | 1221 | Q9P2K8 | |
| TIFRAEDLSVILKAY | 261 | A4D0V7 | |
| LRVLQLDYVDLYIIE | 106 | P51857 | |
| ILKTYEEELLYEIKL | 51 | Q9H2U9 | |
| CVELSRLTKLSKYVY | 386 | Q9NR80 | |
| QYLERLSKIAILEYD | 126 | P0DMQ9 | |
| EDIRKALYASKIISY | 321 | P52209 | |
| VLLALLVNYRKYESV | 211 | Q5T2E6 | |
| RYRELEVKYASLTDL | 171 | O95841 | |
| DRLLSDYIEKEVKYL | 56 | Q9BSQ5 | |
| VTLVYLERLLTYAEI | 191 | Q8ND76 | |
| LIEAITEYTKAVYTL | 96 | Q9NR28 | |
| YIEIETALELTKYLA | 701 | Q6Q4G3 | |
| VSEVNIYDIYSLLKR | 736 | Q6Q4G3 | |
| LNKKLYELIITRYSE | 651 | P07384 | |
| LITIIYSYLESLVKF | 11 | Q7Z5P4 | |
| VTLVYLERLLTYAEI | 211 | Q8N7R7 | |
| LLSSYLVAYRVAKEK | 61 | Q8TCP9 | |
| KNYELLYTSLALITI | 546 | Q14156 | |
| AYLVSRLKENYVLLS | 386 | Q8IUZ5 | |
| TGLILYALSKEIYVI | 81 | P24539 | |
| ELESLYRKIISYVLL | 126 | Q8IYR0 | |
| DIRTIRTSLYGLIKY | 1066 | Q6ZS30 | |
| IEQLEERLKYYRILI | 266 | O75901 | |
| ERLKYYRILIDKLSA | 271 | O75901 | |
| KTYSEDTYRLARILV | 531 | P49116 | |
| DVEINYSLIEIKLYT | 46 | P69849 | |
| YYRLVTTKNLDRETL | 401 | Q9Y5G6 | |
| YYLLTKLESERILAS | 426 | Q5JSJ4 | |
| LKYQLELKDDYIIRT | 351 | O75665 | |
| NYYKLITSRVLDREL | 401 | Q9Y5H2 | |
| VRLDYRISYLLSVFK | 981 | Q14573 | |
| GYKILTSVDQYLELI | 121 | Q96TA1 | |
| YRYLSDLFTTLVDLK | 71 | P48544 | |
| IIIAEYLSYVENRKS | 596 | Q9Y5A7 | |
| SKEYRLQYLASETVL | 611 | Q9UJX4 | |
| DVEINYSLIEIKLYT | 46 | Q5JPE7 | |
| LLYTEVTRYLDFKVT | 91 | P50395 | |
| LYYREILVKELTTSS | 256 | Q15306 | |
| YKFILLENLTSRYEV | 201 | Q9UHH9 | |
| KLEEEIQTLRVYYSL | 331 | Q8TD10 | |
| ARIYTYLLEKSRLVS | 571 | Q9Y6X6 | |
| EKSLYYASFLEVLVR | 171 | O75822 | |
| KLVELYRIVVYLGTS | 101 | P15018 | |
| DLDSEDKSLVYIIRY | 1331 | Q5SZK8 | |
| AVVLRKYADKIYSIS | 601 | Q04609 | |
| YSIYEVQALERKELI | 556 | Q5BJE1 | |
| VKERDLTDIYLLRSY | 76 | Q53EV4 | |
| DLRKVLTTYYVKGII | 1691 | Q96RV3 | |
| IATYRHLLEKEEIRY | 136 | Q8N1A0 | |
| QLVSKSLAYIERDVY | 276 | Q14149 | |
| TSKIDEVLKYYLIRD | 441 | Q8WWZ8 | |
| LTVDARVYSYALALK | 191 | Q9UKK9 | |
| DRLYKLTYSTEVLLD | 31 | P55157 | |
| FKLEKSIDSYYRLVI | 396 | Q9Y5H3 | |
| LLIEKSDAYTKVYSR | 126 | Q02817 | |
| KAARSAIEIYLKLYD | 556 | Q6N069 | |
| DVEINYSLIEIKLYT | 46 | Q15155 | |
| LIIKYLYSASIDLND | 86 | O60662 | |
| VYTQSRILKARLEYL | 626 | P18074 | |
| VRLVTELCLEYKIYD | 1961 | P50748 | |
| VAKEIIYTLKERAYV | 471 | Q9BSJ2 | |
| YYSVETVTLLVALKV | 91 | P62714 | |
| YYSVETVTLLVALKV | 91 | P67775 | |
| RKLLTYLDRLATYEE | 686 | A2RRP1 | |
| YSLKKDRLVSVLYSV | 266 | Q9UGF6 | |
| LITLYIETKAAEYIS | 131 | P52757 | |
| EELTRYLLYLQIKRD | 121 | A2A2Y4 | |
| YSLLIFIYDEVRKLI | 991 | P50993 | |
| LVLLSYERYHSKQII | 1501 | P42858 | |
| IDIYKRILLDNREYL | 171 | A0AVF1 | |
| YEIRYTAISVIKNLL | 1131 | Q5JSL3 | |
| KILEETLYVYELLGV | 286 | O15228 | |
| RVLLQLKYRYDTEID | 2651 | P51587 | |
| KYLIGVLAYLTELAI | 326 | Q8N0S6 | |
| IIEYSRDFKLYITTR | 3161 | Q8TD57 | |
| KNEADRTLIYITLYI | 61 | O15145 | |
| RTLIYITLYISECLK | 66 | O15145 | |
| LDYESRRLYTLKVEA | 336 | Q9Y6N8 | |
| LRYLVIYCASIKELS | 316 | Q9UJT9 | |
| EEYLIVNLVLYLSIA | 486 | Q8NCQ5 | |
| LSDRVYLKTQLETYI | 176 | Q8N4A0 | |
| KDLVQRILYVLTYFL | 511 | Q9P278 | |
| LDAIELTRKLYQYSS | 746 | Q5T1B0 | |
| EEYKLRAETLYLAVN | 256 | P78396 | |
| LDYEVTSAYKLTIRA | 2246 | Q8TDW7 | |
| LYSLGKSVESRELYV | 526 | O75976 | |
| ALINYTRLTEYAKIE | 811 | Q86UW7 | |
| YVTLYVKNIRELVLA | 481 | O00462 | |
| LTYIYSVVLTLVSEK | 646 | Q6ZN28 | |
| KKIIIISDYLEYDSL | 256 | Q16666 | |
| EASIARYKEEYAVLI | 3441 | Q14204 | |
| AALLLVTVAYRLYKS | 26 | Q5VTJ3 | |
| LSKLIDYIYTAEIEV | 101 | Q9UH77 | |
| YVYLVFELEKSVRSL | 361 | Q9BZB8 | |
| LLYTEVTRYLDFKVV | 91 | P31150 | |
| YAKVLLLIDDEYKVT | 636 | Q8N766 | |
| LITLYIETKAAEYIA | 121 | P15882 | |
| KLIISQLLYDGYISI | 16 | Q05048 | |
| DLSDKTLYKYFLRVV | 191 | Q13255 | |
| LLKYIYTGRATLTDE | 91 | Q96Q07 | |
| IVILYARIYFLVKSS | 211 | Q99500 | |
| LISILYVSLTYADLI | 176 | Q9UJA2 | |
| TYFLLTELYLIENKV | 71 | Q9H756 | |
| YLRKTRDYLIKIIDD | 701 | P0DJD0 | |
| KLVDNYYRLVTERTL | 396 | Q9Y5H4 | |
| KVIALTVLASVRIYY | 306 | Q16816 | |
| TLLDVLYYVTRDDLK | 1336 | Q99683 | |
| ESVAILLYLTRKYKV | 66 | P30711 | |
| SEAYIEKYLRSVLAV | 1336 | Q9NQT8 | |
| QERATKAVYYLRLLE | 2086 | Q5T011 | |
| DEKARLIYEDYVSIL | 136 | P49795 | |
| DDDEKISYRYLIIAL | 131 | Q9Y6N5 | |
| IVRTEYYKELAARIV | 421 | Q7Z2T5 | |
| LIYYLQSIARSLKLS | 696 | Q7Z5M5 | |
| IDSLLRKIYEIYSDF | 166 | Q9Y296 | |
| YYVRILSTIDRELLK | 111 | P43686 | |
| RVTSLSGKEYDVLYL | 441 | O95754 | |
| IRTILEYADKVFTYI | 1061 | P35499 | |
| LFELLEKEILYYRKT | 796 | P28370 | |
| SLEYSLRIQKVDVYD | 91 | Q13449 | |
| LKLAEILYYKILETV | 461 | P28749 | |
| TRDRLLLDKIKSYYE | 711 | A1L390 | |
| DRVKSAEAIQLTYYL | 201 | Q96NR3 | |
| VALLRAKYFEELELY | 146 | Q8WW32 | |
| EKTRYETYVQLLVAR | 971 | Q8NDX1 | |
| ILEDAAALISYYVKR | 661 | O75182 | |
| LILYIFTKLSVDLYS | 131 | P53794 | |
| VYRYLLSEKDLILAL | 201 | Q9BYT1 | |
| ARLSALYKLESDYEI | 261 | P41252 | |
| ELSKVREYVQLISVY | 116 | Q6UX06 | |
| REYVQLISVYEKKLL | 121 | Q6UX06 | |
| VRLYEVIDTQTKLYL | 76 | Q9NRH2 | |
| YIATILREILKGLDY | 116 | O00506 | |
| LSTYELIVYLLEDRT | 306 | Q9BSK2 | |
| KIARLYLVSDVLYNS | 591 | O15042 | |
| LLTYVIAYIRDLALE | 506 | O00116 | |
| LETRKSLEVVLYYKA | 1011 | Q96JN2 | |
| KYVVLSDRLVYLTEN | 51 | Q8IXR9 | |
| LDQISRYYITRAKLV | 176 | P61289 | |
| DAESRYLLVLTKNYV | 3036 | Q63HN8 | |
| VITKEYLVNITEYRA | 221 | A0A494C1R9 | |
| ELYKDLILYSSVSVL | 516 | Q9P2K2 | |
| VITKEYLVNITEYRA | 221 | P0CV99 | |
| VTYESRQLKALIYEI | 646 | Q8N4P2 | |
| TLIDVLKYSYVRLVC | 66 | Q86XI8 | |
| LTSYFLEALLKYIVI | 206 | Q6GYQ0 | |
| DVILGTRKTYAIYDL | 306 | Q969N2 | |
| LLVYEALEYAKRALE | 141 | Q96DB5 | |
| SLEYLLLSYNRIVKL | 221 | Q9NR96 | |
| ILYEILLGKATLYAV | 146 | P01850 | |
| DASLKTYLYSVEIKL | 151 | C9JQI7 | |
| KHRIYYITLFSIVLL | 21 | Q93063 | |
| RVYAVICDLKYILIS | 471 | Q8IWV7 | |
| ELYLQRVAELDKITY | 1101 | Q9NTJ3 | |
| ETLREKVYATLEAYT | 391 | P48443 | |
| YIEQRKTIRTILEYA | 1221 | Q9UQD0 | |
| REDTETLIKAVYTLY | 496 | Q9NXF1 | |
| KDLLYRRTKALIDYE | 306 | Q9Y5X3 | |
| KEEILEALVKLYYTL | 156 | Q6PF05 | |
| YLKSVLRELVTYLLF | 216 | Q13563 | |
| YIKTTLRELLVYIVF | 96 | Q9P0L9 | |
| ACYILYLRTLESKLV | 106 | Q9UI14 | |
| LALRRAEEYLILEKY | 101 | P42681 | |
| LDSTQKYLYRDVILE | 31 | P17031 | |
| KLTLAESTRFLDVYL | 541 | Q6ZR37 | |
| KTNDIVRYRVYELII | 176 | Q16401 | |
| KTIISYIDEQFERYL | 116 | Q15019 | |
| EEEKIQRYSILSELY | 381 | Q96Q05 | |
| ILYEILLGKATLYAV | 146 | A0A5B9 | |
| FEIALKALSVLRYIT | 181 | O75800 | |
| RTYVQDLKSIVEDYL | 126 | Q9ULL1 | |
| VTSTKYTRDIYKELL | 41 | P61165 | |
| YTRDIYKELLISLVA | 46 | P61165 | |
| AAIRKLNYTYLISIL | 596 | O75127 | |
| VKYDELYAALTALLA | 961 | Q5T4S7 | |
| VYTALKRGLTAYLEV | 81 | Q6ZS17 | |
| TLYLTLKIEQRERYK | 3271 | Q9Y4A5 | |
| LAIVESDSTIVYYKL | 141 | Q8WW01 | |
| YTVKFDSLLLREAVV | 246 | Q8N5A5 | |
| YDETLLRSKLLYAIE | 1061 | Q15386 | |
| YYLTSAIQLLRKDSI | 161 | Q93070 |